Atul Gawande Steps Down as Haven's CEO
May 13 2020 - 1:38PM
Dow Jones News
By Dave Sebastian
Atul Gawande is stepping down as the chief executive of Haven,
the health-care venture backed by Amazon.com Inc., Berkshire
Hathaway Inc. and JPMorgan Chase.
Dr. Gawande, a prominent surgeon and professor at Harvard
University, is taking on the less operational role of chairman,
while Chief Operating Officer Mitch Betses will manage daily
operations, Haven said Wednesday. The Wall Street Journal
previously reported that Dr. Gawande was in talks to step down from
his role.
Dr. Gawande, who took the helm in July 2018, said the shift
would enable him to focus on policy and advocacy work amid the
Covid-19 pandemic. The venture said it is looking for a new
CEO.
"This will elevate my focus from daily management to supporting
Haven's strategy, board and leadership," Dr. Gawande said.
Haven says it is focused on improving access to primary care,
simplifying insurance coverage and making prescription drugs more
affordable. In response to a question on whether it would replace
doctors or insurance companies, the company on its website says it
is "interested in working with clinicians and insurance companies
to improve the overall health system."
Dr. Gawande's transition as chairman is a sign of the venture's
slow start since its splashy unveiling in January 2018. The
venture's efforts so far have been of limited scope, and it has
been spending much of its early time building data systems on
employee health-care tendencies across Amazon, Berkshire and
JPMorgan Chase, the Journal reported, citing people familiar with
the matter.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
May 13, 2020 13:23 ET (17:23 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Apr 2024 to May 2024
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From May 2023 to May 2024